1. Page top
  2. Top navigation
  3. Main navigation
  4. Left-hand-side navigation
  5. Search box
  6. Content area
  7. Page foot
Any book. Anywhere.

Book details

Protein and Peptide Mass Spectrometry in Drug Discovery

Protein and Peptide Mass Spectrometry in Drug Discovery

 eBook, Published by Wiley   (26 September 2011)

£74.99

Book description

The book that highlights mass spectrometry and its application in characterizing proteins and peptides in drug discovery

An instrumental analytical method for quantifying the mass and characterization of various samples from small molecules to large proteins, mass spectrometry (MS) has become one of the most widely used techniques for studying proteins and peptides over the last decade. Bringing together the work of experts in academia and industry, Protein and Peptide Mass Spectrometry in Drug Discovery highlights current analytical approaches, industry practices, and modern strategies for the characterization of both peptides and proteins in drug discovery.

Illustrating the critical role MS technology plays in characterizing target proteins and protein products, the methods used, ion mobility, and the use of microwave radiation to speed proteolysis, the book also covers important emerging applications for neuroproteomics and antigenic peptides. Placing an emphasis on the pharmaceutical industry, the book stresses practice and applications, presenting real-world examples covering the most recent advances in mass spectrometry, and providing an invaluable resource for pharmaceutical scientists in industry and academia, analytical and bioanalytical chemists, and researchers in protein science and proteomics. Michael L. Gross, PhD, is a Professor in the Departments of Chemistry, Medicine, and Immunology at Washington University in St. Louis. He is also Principal Investigator at the National Institutes of Health (NIH) Research Resource in Mass Spectrometry.

Guodong Chen, PhD, is Principal Scientist in Bioanalytical and Discovery Analytical Sciences at Bristol-Myers Squibb in Princeton, New Jersey. He heads a mass spectrometry group in support of drug discovery as well as development programs in small molecule pharmaceuticals and biologics.

Birendra N. Pramanik, PhD, was a Distinguished Fellow at Schering-Plough Research Institute (SPRI), where he directed the spectroscopy, mass spectrometry, and NMR programs.

View all

Other recommendations

Characterization of Impurities and Degradants Using Mass Spectrometry

Characterization of...

by Guodong Chen

£59.99

The Textbook of Pharmaceutical Medicine

The Textbook of...

by John P Griffin

£179.99

Quantitative Methods for Health Research - A Practical Interactive Guide
to Epidemiology and Statistics

Quantitative Methods for...

by Debbi Stanistreet

£89.99

Pharmacometrics - The Science of Quantitative Pharmacology

Pharmacometrics - The...

by Ene I Ette

£114.99

Pharmacogenomics of Human Drug Transporters - Clinical Impacts

Pharmacogenomics of Human...

by Toshihisa Ishikawa

£84.99

Preclinical Safety Evaluation of Biopharmaceuticals - A Science-Based
Approach to Facilitating Clinical Trials

Preclinical Safety...

by Joy A Cavagnaro

£94.99